(Q43781858)

26 November 2017

title

Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: screening in an infectious disease model (English)

1 reference

26 November 2017

1 reference

1 reference

1 reference

S Suarez

1

1 reference

26 November 2017

P O'Hara

2

1 reference

26 November 2017

M Kazantseva

3

1 reference

26 November 2017

C E Newcomer

4

1 reference

26 November 2017

R Hopfer

5

1 reference

26 November 2017

D N McMurray

6

1 reference

26 November 2017

A J Hickey

7

1 reference

26 November 2017

publication date

1 September 2001

1 reference

26 November 2017

number of pages

5

1 reference

inferred from page(s)

published in

Pharmaceutical Research

1 reference

26 November 2017

volume

18

1 reference

26 November 2017

issue

9

1 reference

26 November 2017

page(s)

1315-1319

1 reference

Therapeutic efficacies of isoniazid and rifampin encapsulated in lung-specific stealth liposomes against Mycobacterium tuberculosis infection induced in mice

26 November 2017

cites work

1 reference

12 December 2020

Side-effects of drug regimens used in short-course chemotherapy for pulmonary tuberculosis. A controlled clinical study

1 reference

12 December 2020

Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: manufacture and characterization

1 reference

12 December 2020

Effect of liposome size and drug release properties on pharmacokinetics of encapsulated drug in rats.

1 reference

12 December 2020

Lung specific stealth liposomes: stability, biodistribution and toxicity of liposomal antitubercular drugs in mice

1 reference

12 December 2020

Tuftsin-bearing liposomes as rifampin vehicles in treatment of tuberculosis in mice

1 reference

12 December 2020

Assessment of a combined preparation of isoniazid, rifampicin and pyrazinamide (Rifater) in the initial phase of chemotherapy in three 6-month regimens for smear-positive pulmonary tuberculosis: a five-year follow-up report

1 reference

12 December 2020

Host-parasite relationships in experimental airborne tuberculosis. 3. Relevance of microbial enumeration to acquired resistance in guinea pigs

1 reference

12 December 2020

Animal model of human disease. Pulmonary tuberculosis. Animal model: Experimental airborne tuberculosis in the guinea pig.

1 reference

12 December 2020

Efficacy of microencapsulated rifampin in Mycobacterium tuberculosis-infected mice

1 reference

12 December 2020

Use of microsphere technology for targeted delivery of rifampin to Mycobacterium tuberculosis-infected macrophages

1 reference

12 December 2020

The use of rifampicin and isoniazid entrapped in liposomes for the treatment of Murine tuberculosis

1 reference

12 December 2020

Mycobacterial infection in guinea pigs

1 reference

12 December 2020

Host-Parasite Relationships in Experimental Airborne Tuberculosis II. Reproducible Infection by Means of an Inoculum Preserved at −70 C

1 reference

12 December 2020

Lymphocyte transformation test for the evaluation of adverse effects of antituberculous drugs

1 reference

12 December 2020

The hepatic toxicity of antituberculosis regimens containing isoniazid, rifampicin and pyrazinamide

1 reference

12 December 2020

Should isoniazid be used in retreatment of tuberculosis despite acquired isoniazid resistance?

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1013094112861

1 reference

26 November 2017

1 reference